Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ISRCTN56596656) titled 'Combination antifungal therapy for candida bloodstream infections' on Dec. 19, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Open (masking not used)
Control: Active
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: Wits Health Consortium
Condition:
Candida spp. Bloodstream Infections
Infections and Infestations
Intervention:
A randomisation sequence was generated using a computer algorithm with permuted blocks stratified by site only.
Step 1 - Dose-selection
Micafungin 100 mg/d IV plus flucytosine 50 mg/kg PO/NG (split QDS)
Micafungin 100 mg/d IV ...